Skip to main content
. Author manuscript; available in PMC: 2021 Dec 15.
Published in final edited form as: Cancer. 2020 Sep 10;126(24):5319–5327. doi: 10.1002/cncr.33175

Table 2.

Univariate model of patient characteristics and overall survival. Note, a lower hazard ratio implies a decreased risk of death.

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia
Characteristic HR (95% CI) Pairwise P Overall P HR (95% CI) Pairwise P Overall P
Sphere Distance to Center
≤10 Miles v. >50 Miles 1.04 (0.96–1.13) 0.29 <.0001 1.05 (0.98–1.13) 0.20 0.0066
10–20 Miles v. >50 Miles 0.76 (0.69–0.84) <.0001 0.94 (0.87–1.03) 0.18
20–50 Miles v. >50 Miles 0.76 (0.70–0.84) <.0001 0.93 (0.86–1.01) 0.10
Charlson-Deyo Score
0 v. 3 0.30 (0.20–0.43) <.0001 <.0001 0.41 (0.31–0.56) <.0001 <.0001
1 v. 3 0.53 (0.35–0.79) 0.0018 0.61 (0.44–0.84) 0.0023
2 v. 3 0.91 (0.56–1.50) 0.71 0.92 (0.62–1.35) 0.66
Gender
Male v. Female 1.16 (1.09–1.24) <.0001 <.0001 1.02 (0.97–1.08) 0.4276 0.4276
Race
African American v. Caucasian 1.57 (1.41–1.74) <.0001 <.0001 1.33 (1.23–1.44) <.0001 <.0001
Asian v. Caucasian 0.95 (0.80–1.12) 0.54 0.97 (0.85–1.10) 0.62
Hispanic/Latinos v. Caucasian 1.48 (1.38–1.59) <.0001 0.94 (0.86–1.01) 0.11
Native American v. Caucasian 1.72 (1.25–2.37) 0.0009 1.03 (0.76–1.40) 0.84
Others v. Caucasian 0.91 (0.68–1.23) 0.54 0.74 (0.55–1.00) 0.0477
Insurance
Government v. Private 1.27 (1.19–1.36) <.0001 <.0001 1.20 (1.13–1.27) <.0001 <.0001
Not Insured v. Private 2.59 (2.32–2.89) <.0001 1.39 (1.25–1.54) <.0001
Community Median Income
< $38,000 v. ≥ $63,000 1.72 (1.57–1.88) <.0001 <.0001 1.32 (1.21–1.42) <.0001 <.0001
$38,000– $63,000 v. ≥ $63,000 1.35 (1.26–1.46) <.0001 1.17 (1.10–1.26) <.0001
Age
≥18 v. <18 5.56 (5.22–5.92) <.0001 <.0001 1.56 (1.46–1.67) <.0001 <.0001
Rural
Yes v. No 0.89 (0.67–1.19) 0.43 0.4325 0.97 (0.77–1.21) 0.76 0.76